Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. MYCN amplification drives an aggressive form of spinal ependymoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Normative data for eight verbal fluency measures in older Danish adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hereditære ataksier og sygdomme i det motoriske neuron

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiUndervisning

Vis graf over relationer

Mutations in the charged multivesicular body protein 2B (CHMP2B) cause frontotemporal dementia (FTD). We report that mice which express FTD-causative mutant CHMP2B at physiological levels develop a novel lysosomal storage pathology characterised by large neuronal autofluorescent aggregates. The aggregates are an early and progressive pathology that occur at 3 months of age and increase in both size and number over time. These autofluorescent aggregates are not observed in mice expressing wild-type CHMP2B, or in non-transgenic controls, indicating that they are a specific pathology caused by mutant CHMP2B. Ultrastructural analysis and immuno- gold labelling confirmed that they are derived from the endolysosomal system. Consistent with these findings, CHMP2B mutation patient brains contain morphologically similar autofluorescent aggregates. These aggregates occur significantly more frequently in human CHMP2B mutation brain than in neurodegenerative disease or age-matched control brains. These data suggest that lysosomal storage pathology is the major neuronal pathology in FTD caused by CHMP2B mutation. Recent evidence suggests that two other genes associated with FTD, GRN and TMEM106B are important for lysosomal function. Our identification of lysosomal storage pathology in FTD caused by CHMP2B mutation now provides evidence that endolysosomal dysfunction is a major degenerative pathway in FTD.

OriginalsprogEngelsk
TidsskriftActa Neuropathologica
Vol/bind130
Udgave nummer4
Sider (fra-til)511-23
Antal sider13
ISSN0001-6322
DOI
StatusUdgivet - okt. 2015

ID: 45967156